Dataset from A Two-part Healthy Volunteer Study to Investigate Both the Interaction of GSK2586184 With Rosuvastatin and Simvastatin and to Compare the Pharmacokinetics of Two Different Formulations of GSK2586184

This study is a Phase I, two-part, open-label study designed to evaluate the effect of
repeated doses of GSK2586184 on the pharmacokinetics (PK) of Simvastatin and Rosuvastatin in
healthy volunteers (Cohort A), and to evaluate the pharmacokinetics of a new tablet
formulation of GSK2586184 in healthy male volunteers (Cohort B). Cohort A is a single
sequence drug interaction study in which 28 subjects (14 female and 14 male subjects) will be
enrolled. Each subject will receive single doses of Simvastatin and Rosuvastatin on two
occasions, once alone and once following administration of repeated doses of GSK2586184.
Cohort B is a 3-way crossover PK study in which 9 male subjects will be randomized (3
subjects to each treatment sequence). Each subject will receive a single dose of the standard
formulation of GSK2586184 with food and two doses of a new formulation of GSK2586184, once
with food and once in a fasted state, according to their treatment sequence, with a 3-day
wash out between doses. The primary aim of the study is to investigate the effects of
GSK2586184 on the pharmacokinetics of the 2 statins and to assess the impact of dosing with
and without food on a new formulation of GSK2586184 tablet.